Paulo Malo, the founder of MALO CLINIC Dental Care, brings advanced implant dentistry to China. Photo: Courtesy of MALO CLINIC China

MALO CLINIC China announced on April 6 that it has closed its B-round financing with 85 million yuan ($13 million).

Established by Paula Malo in Lisbon, Portugal in 1993, MALO CLINIC Dental Care is a global dental medicine chain that integrates research and development, diagnosis and treatment, and denture manufacturing with medical education to provide world-class dental care. It is a global authority in dental medicine and has highly-specialized expertise in the areas of oral implants and aesthetic dentistry. 

The company has already made a name for itself in the Chinese market. Within two years of closing its A-round financing in July 2014, MALO CLINIC China has grown from one clinic to 11 clinics and two denture manufacturing centers in major cities across China. In 2015, it not only established flagship and core clinics in cities such as Beijing, Shanghai, and Guangzhou, Guangdong Province, but also acquired many high-quality dental care businesses. 

The company also cooperated with leading private medical institutions in five other Chinese cities, including Taiyuan in Shanxi Province, Qingdao in Shandong Province and Chengdu in Sichuan Province, to jointly develop MALO CLINIC health centers.

Shao Zongzong, the chairman of MALO CLINIC China, said the company values like-minded and professional partners who are committed to excellence.

"We hope to cooperate with more excellent professional dentists and managerial talents and partners who are engaged in high-quality dental services and have the same philosophy of professional care and ingenious spirit as MALO CLINIC so as to jointly make contributions to the development of China's domestic private stomatological industry," Shao said.

MALO CLINIC China chose GGV Capital as its lead investor in the B-round of financing. 

As the world's leading venture capital investment fund, GGV Capital was also an early investor in a series of unicorn enterprises such as Chinese online commerce giant Alibaba and video provider Youku Tudou. 

Other investors include HighLight Capital, Shanghai Li Ying Investment Management Center and Guangzhou Yi Li Fu Yi Dao He Treatment Investment Fund. Haoyue Capital was the financial consultant for the transaction.